NeurAxis, Inc. (NRXS) Stock Forecast

NYSE American: NRXSAnalyst ratings, price target and estimates.

NRXS analyst forecast

as of October 17, 2026
Analyst consensus
Strong buy
5.00 / 5 from 1 analysts
Price target
$11.00
average of analyst targets
Upside to target
+42.9%
from the latest close
Next earnings
November 9, 2026
EPS estimate $-0.21
52-week range
$2.31 – $8.81

NRXS analyst ratings

1 analysts
Strong buy
1100%
Buy
00%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

NRXS price target

Price $7.70Target $11.00
52-week low $2.3152-week high $8.81

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

NRXS earnings per share estimates

NeurAxis, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.21−$0.21−$0.21−$0.24+12.5%1
Current fiscal year (2026)−$0.76−$0.76−$0.76−$0.88+13.5%1
Next fiscal year (2027)−$0.27−$0.27−$0.27−$0.76+64.5%1

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

NRXS revenue estimates

NeurAxis, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$2.1M$2.1M$2.1M+158.8%1
Current fiscal year (2026)$8.3M$8.3M$8.3M+132.5%1
Next fiscal year (2027)$19.8M$19.8M$19.8M+138.5%1

NRXS EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

NRXS revenue: reported and forecast

Reported revenueEstimate (average; low–high)

NRXS EPS estimate revisions

NeurAxis, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.12−$0.21−$0.21−$0.21−$0.21+82.6%0 up · 0 down
Current fiscal year (2026)−$0.68−$0.76−$0.76−$0.76−$0.76+11.8%0 up · 1 down
Next fiscal year (2027)−$0.06−$0.27−$0.27−$0.27−$0.27+350.0%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

NRXS earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; NRXS beat in 3 of 11.

What analysts expect from NRXS

1 analysts cover NeurAxis; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $11.00, 42.9% above the latest close of $7.70. Analysts expect earnings of −$0.76 per share for 2026, +13.5% from a year earlier. For 2027 the average estimate is −$0.27 per share on revenue of $19.8 million. NeurAxis beat the EPS estimate in 3 of the last 11 quarters.

Related: NRXS income statement, NRXS key metrics, NRXS chart. See the NRXS stock overview for the latest quote and news.

NRXS forecast FAQ

What is NeurAxis's price target?

The average analyst price target for NeurAxis is $11.00, 42.9% above the latest close of $7.70.

Is NeurAxis a buy, hold or sell?

Of 1 analysts covering NeurAxis, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is NeurAxis's EPS forecast?

Analysts forecast −$0.76 per share for 2026 (range −$0.76 to −$0.76); for 2027 the estimate is −$0.27.

What is NeurAxis's revenue forecast?

The average revenue estimate for 2026 is $8.3 million, growth of 132.5%; for 2027 it is $19.8 million.

When does NeurAxis report earnings?

NeurAxis is expected to report results for the quarter ending September 30, 2026 on November 9, 2026; the EPS estimate is $-0.21.

Does NeurAxis usually beat earnings estimates?

NeurAxis reported EPS at or above the analyst estimate in 3 of the last 11 quarters.

Biotechnology: forecast